This panel will address strategies for handling valuation disputes and other post-closing adjustments arising from cannabis M&A, looking at before-the-fact transactional considerations and after-the-fact litigation solutions. We will also consider the availability of state-law restructuring and turnaround remedies given the absence of federal bankruptcy protection for cannabis companies; it’s a hybrid event.
Canada: What Federal Legalization Looks Like 4 years Later and What Have We Learned. This panel explores and reflects on the legislative updates, regulatory challenges, and business opportunities that have evolved over the past four years of federal cannabis legalization in Canada.
Regulating Cannabinoids: A Comparative Analysis of Intoxicating and Non-Intoxicating Models. The focus of this session is to provide an overview of the Farm Bill and dive into a comparative analysis of regulatory models for intoxicating and non-intoxicating cannabinoids across the country.
Navigating the Highs and Lows of Cannabis Regulatory Compliance—Insights, Best Practices, and Hurdles. Examine regulatory compliance “hot topics”, including maintaining state licenses and navigating enforcement actions, and explore best practices for corporate governance, novel partnership agreements such as IP licensing and white labeling, and regulatory considerations of various exit strategies for mature cannabis enterprises.
Panelists will explore the current state of cannabis legalization in various regions throughout the Americas and highlight emerging markets with high growth potential. Attendees will leave this panel with a deeper understanding of the current state and future potential of emerging cannabis markets in the Americas, as well as insights and strategies for success in these exciting and rapidly evolving markets.
Medical Cannabis: Overview of Emerging Legal Issues and their Impact on the International Market. The international panel of experts will notably discuss the differences in regulations between medical cannabis and pharmaceutical cannabis, how IP is becoming an essential topic with pharmaceutical cannabis medicines, and how it could also impact medical cannabis in the short run.
Interstate Commerce in Practice: What will Interstate commerce actually look like, and how will it be regulated? Assuming interstate commerce will commence before federal legalization, this session will probe the nuances of the federal government's posture toward state-regulated interstate sales will impact how products can effectively move from state to state. Presenters will discuss the practical challenges for regulators and operators in establishing an efficient and well-regulated interstate market.
Risky Business: Managing Risk Within a Cannabis Company. From insurance to human resources to employment to governance, an effective risk management policy can save money, prevent liability and put your cannabis company in a position for success. These experts will explore all the aspects of effective risk management within a cannabis company.
Here Comes the Money: Banking and Payment Processing in the Cannabis Industry. Banking and payment processing has long been one of the most misunderstood aspects of operating within the cannabis industry. This panel of experts will explore the current state of banking and payments in cannabis and how to utilize these services legally.